PCA3 and prostate cancer: Regarding EVs in other body fluids, Nilsson et al. [115] reported that PCA3 and TMPRSS2:ERG mRNA,which are previously established prostate cancer biomarkers, were also present in urinaryEVs from prostate cancer patients.